SENSEX   78,782.24

 -941.88

NIFTY   23,995.35

 -309.00

CRUDEOIL   6,029.00

+ 41.00

GOLD   78,420.00

 -447.00

SILVER   94,126.00

 -1,357.00

SENSEX   78,782.24

 -941.88

NIFTY   23,995.35

 -309.00

NIFTY   23,995.35

 -309.00

CRUDEOIL   6,029.00

+ 41.00

CRUDEOIL   6,029.00

+ 41.00

GOLD   78,420.00

 -447.00

MENU Businessline LogoCLOSEBusinessline Logo
ePaper
SEARCH
SEARCH
Companies
Markets
Portfolio
Economy
Opinion
Specials

Get businessline apps on

Play storeApple store

Connect with us

digitalaccessDigital access to daily edition e-Paper
PREMIUMBusinessline Logo

 Johnson & Johnson

Johnson & Johnson

About a year ago, the primary patent on the adult version had lapsed and Indian drugmakers including Lupin, Natco and Macleods had confirmed to businessline, they were making versions of the product.

After patent application rejection, drugmakers need to develop paediatric versions of J&J TB drug, say public health voices

Sign into Unlock benefits!
  • Access 10 free stories per month
  • Access to comment on every story
  • Sign up/Manage to our newsletters
  • Get notified by email for early preview to new features, discounts & offers
Sign in